Elicio Therapeutics Inc.

NASDAQ: ELTX · Real-Time Price · USD
11.80
1.96 (19.92%)
At close: Aug 18, 2025, 1:44 PM

Elicio Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.62M 12.89M 6.16M 9.28M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
696K 685K 617K 723K
Other Long-Term Assets
600K 2.83M 2.83M 2.84M
Receivables
n/a n/a n/a 806K
Inventory
n/a n/a 4.22M 188.96K
Other Current Assets
1.28M 895K -2.54M -758.44K
Total Current Assets
20.69M 16.35M 10.72M 10.36M
Property-Plant & Equipment
6.19M 7.28M 8.5M 890.37K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.49M 10.8M 11.95M 4.46M
Total Assets
28.18M 27.15M 22.66M 14.81M
Account Payables
1.04M 4.37M 2.81M 1.68M
Deferred Revenue
1.17M 694K 1.44M 2.3M
Short-Term Debt
901K 910K 692K 11.8M
Other Current Liabilities
2.31M 1.03M -247.61K 1.85M
Total Current Liabilities
11.52M 9.77M 6.87M 18.88M
Long-Term Debt
20.03M n/a n/a n/a
Other Long-Term Liabilities
2.83M n/a 92K 66.76M
Total Long-Term Liabilities
27.97M 6.01M 6.88M 70.47M
Total Liabilities
39.49M 15.77M 124.81M 89.35M
Total Debt
26.04M 6.92M 7.48M 11.8M
Common Stock
110K 96K 3K 171.43K
Retained Earnings
-194.1M -142.2M -107.01M -78.8M
Comprehensive Income
-175K -197K -111.06M -103K
Shareholders Equity
-11.31M 11.37M 8.91M -74.54M
Total Investments
696K 685K 617K 723K